Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.602, 2010-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gene expression profile predicts survival in breast cancer
Inpharma, Vol. 1, Iss. 1370, 2003-01 ,pp. :
Sorafenib enhances HRQOL in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. :
Temozolomide improves survival, no HRQOL loss in glioblastoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
Preoperative treatment a boon to HRQOL in oesophageal cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. :